About Progen
Progen is a company based in Heidelberg (Germany) founded in 1983. Progen offers products and services including AAV ELISAs, AAV Antibodies, and OptiPrep. Progen operates in a competitive market with competitors including Roche, Abcam, Stem Cell Technologies, SonoSite and EKF, among others.
- Headquarter Heidelberg, Germany
- SectorsHealthcare
- Phone•••• ••••
- Website us.progen.com
- Social LinkedIn X Facebook YouTube
- Legal Name Progen Biotechnik Gmbh
Products & Services of Progen
Progen offers a comprehensive portfolio of products and services, including AAV ELISAs, AAV Antibodies, and OptiPrep.
Kits for detecting AAV capsids in gene therapy research.
Antibodies for analyzing viral vectors in biotechnology.
Media for virus purification and cell separation processes.
Apps and channels of Progen
its YouTube channel PROGEN has 20 subscribers and 4 videos.
Videos from Progen
The most watched videos on Progen's YouTube channel, PROGEN (20 subscribers). Click a video to play it here.
More on PROGEN.
People of Progen
4 people are tracked at Progen (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Gitta Weins | CEO | Leadership |
Katja Betts | co-CEO | Leadership |
Dana Holzinger | Head Of Product Management & Licensing | Leadership |
Caroline Odenwald | Innovationsmanagerin | Team |
Complete people profiles for Progen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Progen
Progen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Abcam, Stem Cell Technologies, SonoSite and EKF, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| roche.com | 1896 | Basel, Switzerland | – | 2,382 | Pharmaceuticals and diagnostics kits are developed for various diseases. | |
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| sonosite.com | 1986 | Bothell, United States | – | 606 | Hand-carried ultrasound systems for medical specialties are developed and distributed. | |
| ekfdiagnostics.com | 1990 | Penarth, United Kingdom | $178,634 | 386 | Point-of-care and laboratory blood analyzers are developed by EKF. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| nvision-imaging.com | 2015 | Ulm, Germany | $30M | 30 | Medical imaging is provided through quantum technologies. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits |
Detailed competitors of Progen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Progen
The website of Progen (progen.com) receives about 16.7K visits a month.
- Monthly visits16.7K
▲ 18.5% vs previous month
Websites whose visitors overlap most with Progen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| metabion.com | 100% | – | #3,974,909 | View details | |
| novusbio.com | 95% | 199.6K | #232,152 | View details | |
| mybiosource.com | 95% | – | #238,129 | View details | |
| bio-m.org | 89% | 13.9K | #1,671,971 | View details | |
| pepperprint.com | 87% | 8.7K | #2,939,581 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Progen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Progen
Complete news archive for Progen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Progen
10 companies that operate in the same segment as Progen (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Progen
Progen was founded in 1983.
Progen is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Gitta Weins is the current CEO of Progen.
Progen was founded in 1983 in Heidelberg, Germany, and operates within the life sciences and molecular diagnostics sectors. Monoclonal and polyclonal antibodies for cell and molecular biology research are supplied, along with antigens, phage-display libraries, and density gradient media. Molecular diagnostic assays and kits for infectious diseases, lipid metabolism, and coagulation are manufactured by the company.
Progen's top competitors include Abcam, Roche and Meridian Bioscience.
Progen offers AAV ELISAs, AAV Antibodies, and OptiPrep.
Progen operates through Progen Biotechnik Gmbh.